NXG Nexgenrx Inc

NEXGENRX INC. ("NexgenRx" or the "Corporation") (TSX VENTURE:NXG) is pleased to
announce its 2012 annual results.


Revenue from transaction fees for the year ended December 31, 2012 was
$4,395,743 representing an increase of 11%. In addition, cost of sales decreased
by 11% and gross profit increased by 20% over the prior year.


The net income for the year was $523,692, or $0.01 per common share, compared
with a loss of ($616,253), or ($0.01) per common share, in the prior year.


"We realized significant financial accomplishments in 2012, with continued
revenue growth producing four consecutive quarters of positive operating cash
flow of $455,651 and generating $523,692 of net income for the year. Organic
growth as a result of renewed multi-year contracts with a number of large
clients in addition to some cost recovery components across our entire book of
business contributed to these positive results." stated Ron Loucks, President
and CEO.


About NexgenRx

NexgenRx is a growing health benefits management company engaged in the design,
management and administration of health benefit plans offered by employers and
other plan sponsors for the benefit of their employees and plan members. More
information on NexgenRx can be found at www.nexgenrx.com .


Caution Regarding Forward-Looking Statements - This news release contains
certain forward looking statements, including statements regarding the business
and anticipated financial performance of the Corporation. These statements are
subject to a number of risks and uncertainties. Actual results may differ
materially from results contemplated by the forward-looking statements. When
relying on forward-looking statements to make decisions, investors and others
should carefully consider the foregoing factors and other uncertainties and
should not place undue reliance on such forward-looking statements.


FOR FURTHER INFORMATION PLEASE CONTACT: 
NexgenRx Inc.
Ronald C. Loucks
President and CEO
416.695.3393 x801


NexgenRx Inc.
Taba Merrikh
Director of Finance
416-695-3393x803
www.nexgenrx.com

Nexgenrx (TSXV:NXG)
Historical Stock Chart
From May 2024 to Jun 2024

Nexgenrx (TSXV:NXG)
Historical Stock Chart
From Jun 2023 to Jun 2024